Ankylosing spondylitis: Difference between revisions
No edit summary |
CSV import |
||
| Line 1: | Line 1: | ||
{{SI}}<br> | |||
{{Infobox medical condition | |||
| name = Ankylosing spondylitis | |||
| image = [[File:0510_Spondylitis_ankylosans_(morbus_bechterew)_anagoria.JPG|250px]] | |||
| caption = X-ray of the spine showing ankylosing spondylitis | |||
| field = [[Rheumatology]] | |||
| synonyms = Bechterew's disease, Marie–Strümpell disease | |||
| symptoms = [[Chronic pain]] and [[stiffness]] in the lower back, [[fatigue]], [[fever]], [[weight loss]] | |||
| complications = [[Uveitis]], [[heart disease]], [[osteoporosis]], [[spinal fusion]] | |||
| onset = Usually between ages 20 and 30 | |||
| duration = Long term | |||
| causes = [[Genetic]] and [[environmental factors]] | |||
| risks = [[HLA-B27]] positive, family history | |||
| diagnosis = [[Physical examination]], [[X-ray]], [[MRI]], [[blood tests]] | |||
| differential = [[Rheumatoid arthritis]], [[psoriatic arthritis]], [[reactive arthritis]] | |||
| treatment = [[NSAIDs]], [[physical therapy]], [[biologics]], [[surgery]] | |||
| medication = [[Adalimumab]], [[etanercept]], [[infliximab]] | |||
| frequency = 0.1% to 0.2% of the population | |||
| deaths = Rare | |||
}} | |||
'''Ankylosing spondylitis''' ('''AS''') is a type of inflammatory [[arthritis]] in which there is a long-term [[inflammation]] of the [[joints]] of the [[Vertebral column|spine]] | '''Ankylosing spondylitis''' ('''AS''') is a type of inflammatory [[arthritis]] in which there is a long-term [[inflammation]] of the [[joints]] of the [[Vertebral column|spine]] | ||
[[File:Primary Area Effected by Ankylosing Spondylitis.png|alt=Primary Area Effected by Ankylosing Spondylitis|thumb|Primary Area Effected by Ankylosing Spondylitis]] | [[File:Primary Area Effected by Ankylosing Spondylitis.png|alt=Primary Area Effected by Ankylosing Spondylitis|thumb|Primary Area Effected by Ankylosing Spondylitis]] | ||
| Line 6: | Line 25: | ||
== Cause == | == Cause == | ||
No one knows the cause of ankylosing spondylitis. Studies show, however, that both genes and things in our environment may lead to the development of the disease. | No one knows the cause of ankylosing spondylitis. Studies show, however, that both genes and things in our environment may lead to the development of the disease. | ||
== Risk factors == | == Risk factors == | ||
* Anyone can get ankylosing spondylitis; however, certain factors may increase your risk for developing the disease, such as: | * Anyone can get ankylosing spondylitis; however, certain factors may increase your risk for developing the disease, such as: | ||
* Family history and genetics. If you have a family history of ankylosing spondylitis, you are more likely to develop the disease. | * Family history and genetics. If you have a family history of ankylosing spondylitis, you are more likely to develop the disease. | ||
* Age. Most people develop symptoms of ankylosing spondylitis before age 45.   | |||
* Age. Most people develop symptoms of ankylosing spondylitis before age 45. | |||
* Sex. Men are more likely to have ankylosing spondylitis than women. | * Sex. Men are more likely to have ankylosing spondylitis than women. | ||
* Other conditions. People who have Crohn’s disease, ulcerative colitis, or psoriasis may be more likely to develop the disease. | |||
* Other conditions. People who have | |||
==Signs and symptoms== | ==Signs and symptoms== | ||
[[File:Blausen 0037 AnkylosingSpondylitis.png|thumb|Illustration depicting ankylosing spondylitis]] | [[File:Blausen 0037 AnkylosingSpondylitis.png|thumb|Illustration depicting ankylosing spondylitis]] | ||
AS is characterized by back pain and stiffness that typically appear in adolescence or early adulthood. Over time, back movement gradually becomes limited as the bones of the spine (vertebrae) fuse together. This progressive bony fusion is called ankylosis. | AS is characterized by back pain and stiffness that typically appear in adolescence or early adulthood. Over time, back movement gradually becomes limited as the bones of the spine (vertebrae) fuse together. This progressive bony fusion is called ankylosis. | ||
== Progressive disease == | == Progressive disease == | ||
* As the disease progresses, loss of spinal mobility and chest expansion, with a limitation of anterior flexion, lateral flexion, and extension of the lumbar spine, are seen. Systemic features are common, with weight loss, fever, or fatigue often present. | * As the disease progresses, loss of spinal mobility and chest expansion, with a limitation of anterior flexion, lateral flexion, and extension of the lumbar spine, are seen. Systemic features are common, with weight loss, fever, or fatigue often present. | ||
* Pain is often severe at rest but may improve with physical activity, but inflammation and pain to varying degrees may recur regardless of rest and movement. | * Pain is often severe at rest but may improve with physical activity, but inflammation and pain to varying degrees may recur regardless of rest and movement. | ||
== Other joint and systemic involvement == | == Other joint and systemic involvement == | ||
* Arthritis in the hips and shoulders may also occur. When the condition presents before the age of 18, it is more likely to cause pain and swelling of large lower limb joints, such as the knees. | * Arthritis in the hips and shoulders may also occur. When the condition presents before the age of 18, it is more likely to cause pain and swelling of large lower limb joints, such as the knees. | ||
| Line 32: | Line 43: | ||
* Cardiovascular involvement may include [[aortitis|inflammation of the aorta]], [[aortic valve insufficiency]] or [[Electrical conduction system of the heart|disturbances of the heart's electrical conduction system]]. | * Cardiovascular involvement may include [[aortitis|inflammation of the aorta]], [[aortic valve insufficiency]] or [[Electrical conduction system of the heart|disturbances of the heart's electrical conduction system]]. | ||
* Lung involvement is characterized by progressive [[lung fibrosis|fibrosis]] of the [[apex of lung|upper portion of the lung]]. | * Lung involvement is characterized by progressive [[lung fibrosis|fibrosis]] of the [[apex of lung|upper portion of the lung]]. | ||
<youtube> | <youtube> | ||
title='''{{PAGENAME}}''' | title='''{{PAGENAME}}''' | ||
| Line 43: | Line 53: | ||
height=600 | height=600 | ||
</youtube> | </youtube> | ||
==Pathophysiology== | ==Pathophysiology== | ||
[[File:Ankylosing process.jpg|thumb|256px|The [[ankylosis]] process]] | [[File:Ankylosing process.jpg|thumb|256px|The [[ankylosis]] process]] | ||
* Ankylosing [[spondylitis]] (AS) is a systemic rheumatic disease, meaning it affects the entire body. | * Ankylosing [[spondylitis]] (AS) is a systemic rheumatic disease, meaning it affects the entire body. | ||
* Approximately 90% of people with AS express the [[HLA-B27]] genotype, meaning there is a strong genetic association. | * Approximately 90% of people with AS express the [[HLA-B27]] genotype, meaning there is a strong genetic association. | ||
* | * 1–2% of individuals with the HLA-B27 genotype develop the disease. | ||
== HLA-B27 association == | == HLA-B27 association == | ||
The association of AS with HLA-B27 suggests the condition involves CD8 T cells, which interact with HLA-B. | The association of AS with HLA-B27 suggests the condition involves CD8 T cells, which interact with HLA-B. | ||
== Bamboo spine == | == Bamboo spine == | ||
"Bamboo spine" develops when the outer fibers of the [[Anulus fibrosus disci intervertebralis|fibrous ring]] (''anulus fibrosus disci intervertebralis'') of the [[intervertebral disc]]s ossify, which results in the formation of marginal [[syndesmophyte]]s between adjoining vertebrae. | "Bamboo spine" develops when the outer fibers of the [[Anulus fibrosus disci intervertebralis|fibrous ring]] (''anulus fibrosus disci intervertebralis'') of the [[intervertebral disc]]s ossify, which results in the formation of marginal [[syndesmophyte]]s between adjoining vertebrae. | ||
| Line 58: | Line 65: | ||
==Diagnosis== | ==Diagnosis== | ||
[[Image:12891 2006 Article 297 Fig5 HTML.jpg|thumb|34-year-old male with AS. Inflammatory lesions of the anterior chest wall are shown (curved arrows). Inflammatory changes are seen in the lower thoracic spine and L1 (arrows).]] | [[Image:12891 2006 Article 297 Fig5 HTML.jpg|thumb|34-year-old male with AS. Inflammatory lesions of the anterior chest wall are shown (curved arrows). Inflammatory changes are seen in the lower thoracic spine and L1 (arrows).]] | ||
===Schober's test=== | ===Schober's test=== | ||
The [[Schober's test]] is a useful clinical measure of flexion of the lumbar spine performed during the physical examination. | The [[Schober's test]] is a useful clinical measure of flexion of the lumbar spine performed during the physical examination. | ||
==Treatment== | ==Treatment== | ||
There is no cure for AS, although treatments and medications can reduce symptoms and pain. | There is no cure for AS, although treatments and medications can reduce symptoms and pain. | ||
| Line 71: | Line 76: | ||
File:Costovertebrale Ankylose bei Morbus Bechterew CT.jpg|alt=Costovertebral Ankylosis|'''Costovertebral Ankylosis''' | File:Costovertebrale Ankylose bei Morbus Bechterew CT.jpg|alt=Costovertebral Ankylosis|'''Costovertebral Ankylosis''' | ||
</gallery> | </gallery> | ||
===Medication=== | ===Medication=== | ||
*The mainstay of therapy in all seronegative spondyloarthropathies are [[anti-inflammatory drugs]], which include [[Non-steroidal anti-inflammatory drug|NSAID]]s such as [[ibuprofen]], [[phenylbutazone]], [[diclofenac]], [[indomethacin]], [[naproxen]] and [[COX-2 inhibitor]]s, which reduce inflammation and pain. | *The mainstay of therapy in all seronegative spondyloarthropathies are [[anti-inflammatory drugs]], which include [[Non-steroidal anti-inflammatory drug|NSAID]]s such as [[ibuprofen]], [[phenylbutazone]], [[diclofenac]], [[indomethacin]], [[naproxen]] and [[COX-2 inhibitor]]s, which reduce inflammation and pain. | ||
Medications used to treat the progression of the disease include the following: | Medications used to treat the progression of the disease include the following: | ||
*[[Disease-modifying antirheumatic drug]]s (DMARDs) such as [[sulfasalazine]] can be used in people with peripheral arthritis. For axial involvement, evidence does not support sulfasalazine. | *[[Disease-modifying antirheumatic drug]]s (DMARDs) such as [[sulfasalazine]] can be used in people with peripheral arthritis. For axial involvement, evidence does not support sulfasalazine. | ||
*[[Tumor necrosis factor-alpha]] ( | *[[Tumor necrosis factor-alpha]] (TNFα) blockers ([[Receptor antagonist|antagonists]]), such as the [[biologic medical product|biologics]] [[etanercept]], [[infliximab]], [[golimumab]] and [[adalimumab]], have shown good short-term effectiveness in the form of profound and sustained reduction in all clinical and laboratory measures of disease activity. | ||
*[[Anti-IL-6|Anti-interleukin-6]] inhibitors such as [[tocilizumab]], currently approved for the treatment of rheumatoid arthritis | *[[Anti-IL-6|Anti-interleukin-6]] inhibitors such as [[tocilizumab]], currently approved for the treatment of rheumatoid arthritis | ||
*[[Interleukin 17A|Interleukin-17A]] inhibitor [[secukinumab]] is an option for the treatment of active ankylosing spondylitis that has responded inadequately to ( | *[[Interleukin 17A|Interleukin-17A]] inhibitor [[secukinumab]] is an option for the treatment of active ankylosing spondylitis that has responded inadequately to (TNFα) blockers. | ||
===Surgery=== | ===Surgery=== | ||
In severe cases of AS, surgery can be an option in the form of joint replacements, particularly in the knees and hips. | In severe cases of AS, surgery can be an option in the form of joint replacements, particularly in the knees and hips. | ||
| Line 86: | Line 89: | ||
Changes in the upper airway can lead to difficulties in intubating the airway, spinal and epidural anesthesia may be difficult owing to calcification of ligaments, and a small number of people have [[aortic insufficiency]]. | Changes in the upper airway can lead to difficulties in intubating the airway, spinal and epidural anesthesia may be difficult owing to calcification of ligaments, and a small number of people have [[aortic insufficiency]]. | ||
The stiffness of the thoracic ribs results in ventilation being mainly diaphragm-driven, so there may also be a decrease in pulmonary function. | The stiffness of the thoracic ribs results in ventilation being mainly diaphragm-driven, so there may also be a decrease in pulmonary function. | ||
===Physical therapy=== | ===Physical therapy=== | ||
Though physical therapy remedies have been scarcely documented, some therapeutic exercises are used to help manage lower back, neck, knee, and shoulder pain. | Though physical therapy remedies have been scarcely documented, some therapeutic exercises are used to help manage lower back, neck, knee, and shoulder pain. | ||
| Line 96: | Line 98: | ||
* Hydrotherapy | * Hydrotherapy | ||
* Group exercises eg [[Pilates]] | * Group exercises eg [[Pilates]] | ||
== Other names == | == Other names == | ||
* Bechterew disease | * Bechterew disease | ||
Latest revision as of 14:09, 4 April 2025

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC
| Ankylosing spondylitis | |
|---|---|
| Synonyms | Bechterew's disease, Marie–Strümpell disease |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Chronic pain and stiffness in the lower back, fatigue, fever, weight loss |
| Complications | Uveitis, heart disease, osteoporosis, spinal fusion |
| Onset | Usually between ages 20 and 30 |
| Duration | Long term |
| Types | N/A |
| Causes | Genetic and environmental factors |
| Risks | HLA-B27 positive, family history |
| Diagnosis | Physical examination, X-ray, MRI, blood tests |
| Differential diagnosis | Rheumatoid arthritis, psoriatic arthritis, reactive arthritis |
| Prevention | N/A |
| Treatment | NSAIDs, physical therapy, biologics, surgery |
| Medication | Adalimumab, etanercept, infliximab |
| Prognosis | N/A |
| Frequency | 0.1% to 0.2% of the population |
| Deaths | Rare |
Ankylosing spondylitis (AS) is a type of inflammatory arthritis in which there is a long-term inflammation of the joints of the spine

Ankylosing spondylitis is a form of ongoing joint inflammation (chronic inflammatory arthritis) that primarily affects the spine.

Cause[edit]
No one knows the cause of ankylosing spondylitis. Studies show, however, that both genes and things in our environment may lead to the development of the disease.
Risk factors[edit]
- Anyone can get ankylosing spondylitis; however, certain factors may increase your risk for developing the disease, such as:
- Family history and genetics. If you have a family history of ankylosing spondylitis, you are more likely to develop the disease.
- Age. Most people develop symptoms of ankylosing spondylitis before age 45.  
- Sex. Men are more likely to have ankylosing spondylitis than women.
- Other conditions. People who have Crohn’s disease, ulcerative colitis, or psoriasis may be more likely to develop the disease.
Signs and symptoms[edit]

AS is characterized by back pain and stiffness that typically appear in adolescence or early adulthood. Over time, back movement gradually becomes limited as the bones of the spine (vertebrae) fuse together. This progressive bony fusion is called ankylosis.
Progressive disease[edit]
- As the disease progresses, loss of spinal mobility and chest expansion, with a limitation of anterior flexion, lateral flexion, and extension of the lumbar spine, are seen. Systemic features are common, with weight loss, fever, or fatigue often present.
- Pain is often severe at rest but may improve with physical activity, but inflammation and pain to varying degrees may recur regardless of rest and movement.
Other joint and systemic involvement[edit]
- Arthritis in the hips and shoulders may also occur. When the condition presents before the age of 18, it is more likely to cause pain and swelling of large lower limb joints, such as the knees.
- About 40% of people with AS will also experience inflammation of the anterior chamber of the eye
- Inflammation of the prostate occurs with increased frequency in men.
- Cardiovascular involvement may include inflammation of the aorta, aortic valve insufficiency or disturbances of the heart's electrical conduction system.
- Lung involvement is characterized by progressive fibrosis of the upper portion of the lung.
Pathophysiology[edit]

- Ankylosing spondylitis (AS) is a systemic rheumatic disease, meaning it affects the entire body.
- Approximately 90% of people with AS express the HLA-B27 genotype, meaning there is a strong genetic association.
- 1–2% of individuals with the HLA-B27 genotype develop the disease.
HLA-B27 association[edit]
The association of AS with HLA-B27 suggests the condition involves CD8 T cells, which interact with HLA-B.
Bamboo spine[edit]
"Bamboo spine" develops when the outer fibers of the fibrous ring (anulus fibrosus disci intervertebralis) of the intervertebral discs ossify, which results in the formation of marginal syndesmophytes between adjoining vertebrae.
Diagnosis[edit]

Schober's test[edit]
The Schober's test is a useful clinical measure of flexion of the lumbar spine performed during the physical examination.
Treatment[edit]
There is no cure for AS, although treatments and medications can reduce symptoms and pain.
-
Ankylosing spondylitis
-
Ankylosing spondylitis
-
Bone Density Test
-
Ankylosing spondylitis
-
Costovertebral Ankylosis
Medication[edit]
- The mainstay of therapy in all seronegative spondyloarthropathies are anti-inflammatory drugs, which include NSAIDs such as ibuprofen, phenylbutazone, diclofenac, indomethacin, naproxen and COX-2 inhibitors, which reduce inflammation and pain.
Medications used to treat the progression of the disease include the following:
- Disease-modifying antirheumatic drugs (DMARDs) such as sulfasalazine can be used in people with peripheral arthritis. For axial involvement, evidence does not support sulfasalazine.
- Tumor necrosis factor-alpha (TNFα) blockers (antagonists), such as the biologics etanercept, infliximab, golimumab and adalimumab, have shown good short-term effectiveness in the form of profound and sustained reduction in all clinical and laboratory measures of disease activity.
- Anti-interleukin-6 inhibitors such as tocilizumab, currently approved for the treatment of rheumatoid arthritis
- Interleukin-17A inhibitor secukinumab is an option for the treatment of active ankylosing spondylitis that has responded inadequately to (TNFα) blockers.
Surgery[edit]
In severe cases of AS, surgery can be an option in the form of joint replacements, particularly in the knees and hips. Surgical correction is also possible for those with severe flexion deformities (severe downward curvature) of the spine, particularly in the neck, although this procedure is considered very risky. In addition, AS can have some manifestations which make anesthesia more complex. Changes in the upper airway can lead to difficulties in intubating the airway, spinal and epidural anesthesia may be difficult owing to calcification of ligaments, and a small number of people have aortic insufficiency. The stiffness of the thoracic ribs results in ventilation being mainly diaphragm-driven, so there may also be a decrease in pulmonary function.
Physical therapy[edit]
Though physical therapy remedies have been scarcely documented, some therapeutic exercises are used to help manage lower back, neck, knee, and shoulder pain.
- Low intensity aerobic exercise
- Transcutaneous electrical nerve stimulation (TENS)
- Thermotherapy
- Proprioceptive neuromuscular facilitation (PNF)
- Exercise programs, either at home or supervised
- Hydrotherapy
- Group exercises eg Pilates
Other names[edit]
- Bechterew disease
- Marie-Struempell disease
- spondylarthritis ankylopoietica
- spondylitis ankylopoietica
- spondylitis, ankylosing
- spondyloarthritis ankylopoietica
|
|
|
| Diseases of joints | ||||||||
|---|---|---|---|---|---|---|---|---|
|
| Spinal disease | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|


